Figure 3b.

ADHD Rating Scale total scores as a function of time for a flexible-dose study of modafinil efficacy for children and adolescents with attention-deficit/hyperactivity disorder (n = 244). *p values <0.05; endpoint represents the last obtained value carried forward. Reproduced from: Cephalon, Inc. 2006. Modafinil (CEP-1538) tablets Supplemental NDA 20-717/S-019 ADHD indication. Briefing document for Psychopharmacologic Drugs Advisory Committee Meeting March 26, 2006. Frazer, PA: Cephalon, Inc.